3

PRIMARY DOCUMENT

Company: NovaBay Pharmaceuticals, Inc.
Filed: October 5, 2011
Period of Report: October 4, 2011
Accession Number: 0001437749-11-007395

View Document ↗ View on SEC.gov ↗